These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8562391)

  • 1. Motility of rhG-CSF-induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis.
    Azzarà A; Carulli G; Rizzuti-Gullaci A; Minnucci S; Capochiani E; Ambrogi F
    Br J Haematol; 1996 Jan; 92(1):161-8. PubMed ID: 8562391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
    Kuni-Eda Y; Okabe M; Kurosawa M; Maekawa I; Higuchi M; Kawamura M; Morioka M; Suzuki S; Ohmura T; Fujimoto N
    Leuk Lymphoma; 1995 Feb; 16(5-6):471-6. PubMed ID: 7540462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.
    Azzarà A; Carulli G; Rizzuti-Gullaci A; Capochiani E; Petrini M
    Am J Hematol; 2001 Apr; 66(4):306-7. PubMed ID: 11279646
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
    Hansen PB; Johnsen HE; Ralfkiaer E; Jensen L; Gaarsdal E; Hansen NE
    Leuk Lymphoma; 1995 Nov; 19(5-6):453-60. PubMed ID: 8590846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma.
    Yoshida T; Nakamura S; Ohtake S; Okafuji K; Kobayashi K; Kondo K; Kanno M; Matano S; Matsuda T; Kanai M
    Cancer; 1990 Nov; 66(9):1904-9. PubMed ID: 1699654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. fMLP-induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony-stimulating factor.
    Carulli G; Azzarà A; Minnucci S; Angiolini C; Sbrana S; Ambrogi F
    J Exp Clin Cancer Res; 1997 Sep; 16(3):301-8. PubMed ID: 9387905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
    Itoh Y; Kuratsuji T; Tsunawaki S; Aizawa S; Toyama K
    Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy.
    Carulli G; Papineschi F; Benedetti E; Vanacore R; Azzarà A; Petrini M
    Haematologica; 1999 Mar; 84(3):281-3. PubMed ID: 10189399
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant granulocyte colony-stimulating factor induces production of human neutrophil peptides in lung cancer patients with neutropenia.
    Ashitani J; Nakazato M; Mukae H; Taniguchi H; Date Y; Matsukura S
    Regul Pept; 2000 Nov; 95(1-3):87-92. PubMed ID: 11062337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: neutrophil alkaline phosphatase activity as an endogenous marker.
    Katoh M; Shirai T; Shikoshi K; Ishii M; Saito M; Kitagawa S
    Eur J Haematol; 1992 Jul; 49(1):19-24. PubMed ID: 1379938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
    Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
    Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy.
    Hansen PB; Johnsen HE; Ralfkiaer E; Hansen NE
    Br J Haematol; 1993 Aug; 84(4):581-5. PubMed ID: 7692936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils.
    Zucca A; Brizzi S; Riccioni R; Azzarà A; Ghimenti M; Carulli G
    Clin Ter; 2006; 157(1):19-24. PubMed ID: 16669548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
    Misaki M; Ueyama Y; Tsukamoto G; Matsumura T
    Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of recombinant human granulocyte colony-stimulating factor on neutrophil morphology, function and phenotype in patients with acute leukemia undergoing chemotherapy].
    Huang HH; Zhong JH; Han XF; Xuan ZH; Han JY; Chen FY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1033-7. PubMed ID: 16403274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
    Shi YK; Zhou JC; Feng FY
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A double-blind, cross-over clinical trial of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma].
    Oyama A; Ota K; Asano S; Takaku F; Yoshida Y; Uzuka Y; Omine M; Furusawa S; Takatani O; Sawada U
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2533-48. PubMed ID: 1702132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
    Takano H; Sawada K; Sato N; Natoya A; Tarumi T; Hirayama S; Koizumi K; Takahashi TA; Sekiguchi S; Koike T
    Leuk Lymphoma; 1996 May; 21(5-6):473-8. PubMed ID: 9172813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.